Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,027.00
Bid: 3,041.00
Ask: 3,043.00
Change: 31.00 (1.03%)
Spread: 2.00 (0.066%)
Open: 3,001.00
High: 3,042.00
Low: 2,999.00
Prev. Close: 2,996.00
WTB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 Trading Update

22 Jun 2023 07:00

RNS Number : 5042D
Whitbread PLC
22 June 2023
 

Total revenue up 19%, strong trading momentum and positive outlook

 

Throughout this release percentage growth comparisons are made comparing Q1 FY24 performance for the 13 weeks to 1 June 2023 with the same period in FY23, unless stated otherwise

 

Summary

· Premier Inn UK delivered an outstanding performance during the first quarter:

o Total UK accommodation sales were up 18% vs FY23 and UK LFL accommodation sales up 16% vs FY23 with strong demand from both business and leisure guests across the Regions and London

o RevPAR +16% ahead of FY23 and +40% vs FY20. Continued outperformance versus the wider midscale and economy ('M&E') market1 with a RevPAR premium of £6.18 (Q1 FY23: £5.76)

o UK food and beverage ('F&B') sales were 10% ahead vs FY23 which benefited from several commercial initiatives put in place during the second half of FY23

· Premier Inn Germany also made good progress, led by our cohort of 18 more established hotels which is continuing to mature in line with our expectations. RevPAR for this cohort increased to €63 (Q1 FY23: €44) and total RevPAR for the entire German estate increased to €55 (Q1 FY23: €35)

· The strength of our overall performance and forward booked position has increased our confidence in being able to deliver a strong first half result in FY24

· Trading momentum is strong and we remain positive about the full year outlook

· £300m share buy-back is on-track with 3.1m shares purchased so far at a total cost of c.£103m

· Interim results will be announced on 18 October 2023

Dominic Paul, Chief Executive said:

"In the UK, our market leading brand and value-led customer proposition is continuing to deliver impressive revenue growth and a healthy RevPAR premium versus the wider M&E market. The structural reduction in hotel supply, coupled with strong consumer demand, is highlighting the strengths of our differentiated business model, as evidenced by our continued strong performance. Our forward booked position into Q2 underpins our confidence in being able to deliver a strong first half result.

"In Germany, we now have 56 hotels with 10,000 rooms open, and a further 32 hotels and 6,000 rooms in the pipeline. Overall market demand continued to recover during the first quarter. Our cohort of 18 more established hotels is continuing to perform in line with the market and we have been encouraged by the performance of our less mature cohorts that are starting to follow a similar trajectory. The continued recovery of the wider German market, the performance of our more established hotels and encouraging guest scores across all of our hotels mean we remain confident in achieving our long-term target of 10-14% returns on capital.

"Our business is in great shape and trading well. Given the lack of branded supply growth and permanent decline in the independent sector, I am confident that our business model will continue to deliver as we strengthen Premier Inn's position in the UK, unlock our potential in Germany and maximise long-term returns for our shareholders."

Q1 Financial Performance2

 

 

vs last year (FY23)

 

UK

Germany2

Total

Sales growth:

 

 

 

Accommodation

18%

129%

23%

Food & beverage

10%

100%

12%

Total

16%

124%

19%

Like-for-like sales growth:

Accommodation

16%

66%

18%

Food & beverage

9%

47%

10%

Total

14%

63%

15%

 

1: STR data, standard basis, 3 March 2023 to 1 June 2023, M&E market excludes Premier Inn

2: LFL sales in Germany: FY23: 38 sites

Q1 performance

 

Consumer demand in the UK has remained strong and Premier Inn delivered an excellent operational and financial performance. Whilst there was good revenue growth in both the Regions and London, demand was particularly strong in London that led to a marked increase in ARRs. We opened 348 new rooms across the UK and Ireland and remain on course to open a total of 1,500-2,000 new rooms in FY24, most of which will open in the second half of the year.

In F&B, the encouraging start to the quarter has continued and total sales were up 10% versus last year. While trading at the value end of the pub restaurant market remains challenging, we have been pleased with the positive impact of a number of commercial initiatives introduced in FY23. We are continuing to explore a variety of options to optimise our F&B offer whilst maintaining a quality experience for our Premier Inn guests.

In Germany, the recovery in market demand continued during the first quarter. We have 56 open hotels and a further 32 in the pipeline and remain on course to open 1,000-1,500 rooms in FY24. Our cohort of 18 more established hotels continues to trade in line with the wider market, achieving a RevPAR of €63 (Q1 FY23: €44) which is 45% ahead of the same period last year.

 

Outlook

 

With strong trading momentum across the Group, we remain confident in the full year outlook. Forward booked revenue in the UK is well ahead of last year and in Germany we remain on course and expect to reach break-even on a run-rate basis during calendar year 2024.

 

Extension of existing debt facility

 

The Group is pleased to have extended its existing £775m revolving credit facility (RCF), that remains undrawn, for a further 12 months to May 2028. The five-year facility is provided by a syndicate of seven banks led by Banco Santander, Barclays, NatWest and Bank of China. The RCF has variable interest rates with GBP linked to SONIA and EUR being linked to EURIBOR.

 

For more information please contact:

Investor Relations - Whitbread investorrelations@whitbread.com

Peter Reynolds, Director of Investor Relations peter.reynolds@whitbread.com

Sophie Nottage, Investor Relations Manager sophie.nottage@whitbread.com

 

Media - Teneo whitbread@teneo.com

Jessica Reid +44 (0) 20 7353 4200

 

 

A live Q&A teleconference for investors and analysts will be hosted by Dominic Paul and Hemant Patel at 8:00am BST on 22 June 2023. Details to join are noted below. An on-demand version will be made available on the Group's website: (www.whitbread.com/investors/results-reports-and-presentations) later today.

 

Q&A teleconference participant dial-in numbers:

Start time - 8:00am BST

United Kingdom (Local): 020 3936 2999

All other locations: +44 203 936 2999

Participant Access Code: 804213

Appendix

 

1) Premier Inn UK key performance indicators

 

FY23

FY24

 

Q1

Q2

Q3

Q4

Full Year

Q1

Q12

%

London

 

 

 

 

Occupancy (full inventory)

83.4%

87.1%

87.3%

76.8%

83.6%

81.2%

(2.2)pp

Average room rate (£)

85.57

102.60

107.06

93.07

97.31

111.71

30.5%

Revenue per available room (£)

71.38

89.37

93.46

71.50

81.37

90.76

27.2%

Total accommodation sales (£m)

91.1

114.2

119.9

94.0

419.3

120.8

32.5%

 

 

 

Regions

 

 

 

 

Occupancy (full inventory)

82.4%

87.1%

85.1%

75.7%

82.6%

83.1%

0.7pp

Average room rate (£)

63.37

74.87

68.20

58.54

66.54

71.06

12.1%

Revenue per available room (£)

52.23

65.20

58.03

44.31

54.94

59.06

13.1%

Total accommodation sales (£m)

326.3

408.4

363.1

277.9

1,375.7

372.0

14.0%

 

 

 

Total

 

 

 

 

Occupancy (full inventory)

82.6%

87.1%

85.5%

75.9%

82.7%

82.8%

0.2pp

Average room rate (£)

67.17

79.57

74.95

64.60

71.84

78.02

16.1%

Revenue per available room (£)

55.48

69.30

64.06

49.02

59.45

64.59

16.4%

Total accommodation sales (£m)

417.4

522.6

483.0

371.9

1,795.0

492.8

18.0%

 

 

RevPAR premium vs M&E market1

+£5.76

+£5.35

+£4.56

+£4.32

+£4.97

+£6.18

+£0.42

 

 

 

 

F&B

 

 

 

Total food and beverage sales (£m)

176.2

181.8

177.7

177.1

712.7

193.7

9.9%

 

Total UK sales (£m)

593.6

704.4

660.7

549.0

2,507.7

686.5

15.6%

 

 

 

2) Premier Inn Germany key performance indicators

 

 

 

FY23

 

 

FY24

 

 

Q1

Q2

Q3

Q4

Full Year

Q1

Q12

%

Occupancy (full inventory)

57.1%

69.0%

61.9%

50.0%

59.4%

64.5%

7.4pp

Average room rate (€)

61.85

67.61

88.30

69.05

72.30

84.81

37.1%

Revenue per available room (€)

35.31

46.66

54.67

34.56

42.94

54.67

54.8%

Total accommodation sales (€m)

21.0

31.5

38.2

25.5

116.1

46.2

120.4%

Total food and beverage sales (€m)

4.0

5.4

5.9

4.9

20.2

7.7

92.5%

Total sales (€m)

24.9

36.9

44.1

30.4

136.3

53.8

115.9%

 

Notes:

1: RevPAR STR data, standard inventory basis, 4 March 2022 to 1 June 2023, M&E market excludes Premier Inn

2: Sales growth versus FY23

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFBMFTMTITBIJ
Date   Source Headline
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20241:24 pmRNSDirector/PDMR Shareholding
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20244:42 pmRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20243:34 pmRNSTotal Voting Rights
1st May 20243:02 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:05 amRNSShare Repurchase Programme
30th Apr 20247:00 amRNSPreliminary Results Announcement
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20244:36 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20244:53 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20244:20 pmRNSDirector/PDMR Shareholding
9th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20242:48 pmRNSDirector/PDMR Shareholding
29th Jan 202410:52 amRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSShare Repurchase Programme
25th Jan 20249:51 amRNSBlock listing Interim Review
24th Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20243:52 pmRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20244:32 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNS3rd Quarter Results
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20249:42 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.